Stocktoria

COLLEGIUM PHARMACEUTICAL, INC COLL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-05-07 · LEI

COLLEGIUM PHARMACEUTICAL, INC statistics & valuation

Market cap$1.2B
P / E18.9×
P / S1.5×
P / B3.9×
P / FCF3.6×
Net margin8.1%
Return on equity20.8%
FCF margin42.0%
Return on capital14.8%
Graham number -33.1%$17.20

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($17.20); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-5504.10% -262.90% -14.00% -7.70% 8.60% 25.80% -5.40% 8.50% 11.00% 8.10% 2016201720182019202020212022202320242025
Gross margin (%)
40.90% 34.70% 58.00% 54.40% 45.20% 57.50% 59.80% 59.30% 2016201720182019202020212022202320242025
Operating margin (%)
-5498.70% -264.90% -7.40% -8.00% 18.10% 6.40% 7.20% 29.50% 26.90% 23.00% 2016201720182019202020212022202320242025
Return on equity (%)
-69.80% -71.90% -42.70% -26.00% 14.40% 35.20% -12.80% 24.60% 30.20% 20.80% 2016201720182019202020212022202320242025
Shares outstanding
29.4M 32.8M 33.3M 33.7M 35.2M 41.0M 33.8M 41.8M 40.4M 39.7M 2016201720182019202020212022202320242025
Net debt ($)
-$149.1M -$135.1M -$158.5M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-58.10% -55.20% -13.40% -7.40% 4.20% 10.30% -2.10% 4.20% 4.20% 3.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-4414.40% -238.80% 58.50% 7.20% 28.50% 36.70% 26.40% 48.40% 32.20% 42.00% 2016201720182019202020212022202320242025
Debt / equity (×)
0.03× 0.13× 0.13× 2016201720182019202020212022202320242025
EPS ($)
-$1.19 -$0.68 $0.76 $1.86 -$0.74 $1.29 $1.86 $1.73 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

COLLEGIUM PHARMACEUTICAL, INC trades at about 14.9× earnings — below its 10-year norm (10-year range 9.6×–31.8×, median 25.6×).

9.6× 31.8×

Shaded band = 10-year range (9.6×–31.8×); dot = today's 14.9×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin59.3%59.8%57.5%45.2%54.4%58.0%34.7%40.9%——
Operating margin23.0%26.9%29.5%7.2%6.4%18.1%-8.0%-7.4%-264.9%-5498.7%
Net margin8.1%11.0%8.5%-5.4%25.8%8.6%-7.7%-14.0%-262.9%-5504.1%
FCF margin42.0%32.2%48.4%26.4%36.7%28.5%7.2%58.5%-238.8%-4414.4%
Return on assets3.8%4.2%4.2%-2.1%10.3%4.2%-7.4%-13.4%-55.2%-58.1%
Return on equity20.8%30.2%24.6%-12.8%35.2%14.4%-26.0%-42.7%-71.9%-69.8%
Debt / equity——————0.13×0.13×—0.03×
Current ratio1.570.951.170.971.131.161.271.264.246.20

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.